Priscilla W. Gikandi
Riyadh, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Retinal oxygen metabolism and ocular blood flow in patients with diabetic retinopathy of varying severity.
Journal: Acta ophthalmologica
Published: March 01, 2026
Treatment Initiation within the Therapeutic Window of Opportunity in Acute Uveitic Phase of Vogt-Koyanagi-Harada Disease Preserves Photoreceptor Function.
Journal: Ocular immunology and inflammation
Published: February 03, 2026
Predictive Factors for Macular Sensitivity and Fixation Stability After Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment Repair with Primary Pars Plana Vitrectomy: A Microperimetry Study.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: November 10, 2025
Ocular blood flow and retinal oxygen saturation measurements in central retinal artery occlusion.
Journal: Acta ophthalmologica
Published: October 16, 2025
Dysregulated hyaluronan metabolism drives inflammation and angiogenesis in proliferative diabetic retinopathy.
Journal: Frontiers in immunology
Published: October 13, 2025
A key role of the PGC-1α/ERR-α pathway in regulation of angiogenic factors in proliferative diabetic retinopathy.
Journal: Frontiers in endocrinology
Published: April 20, 2025
Pentraxin 3 is a Novel Inflammatory Marker of HLA-B27-associated Uveitis.
Journal: Ocular immunology and inflammation
Published: April 15, 2025
Patterns and Outcomes of Pediatric Uveitis in a University-Based Tertiary Referral Center in Riyadh, Saudi Arabia.
Journal: Ocular immunology and inflammation
Published: December 05, 2024
ADAMTS13 Improves Endothelial Function and Reduces Inflammation in Diabetic Retinopathy.
Journal: Cells
Published: October 20, 2024
Pretreatment ocular blood flow and retinal oxygen metabolism in the acute uveitic phase is associated with final outcome in Vogt-Koyanagi-Harada disease.
Journal: Acta ophthalmologica
Published: December 20, 2023
CD40 Ligand-CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy.
Journal: International journal of molecular sciences
Published: August 01, 2023
Last Updated: 09/26/2026